Advanced search
Publication Cover
Future Oncology Volume 7, 2011 - Issue 8
Submit an article Journal homepage
236
Views
0
CrossRef citations to date
0
Altmetric
Review

Cancer Stem Cells in the Human Mammary Gland and Regulation of Their Differentiation by Estrogen

Bruno M Simões1 CIC bioGUNE, Cell Biology & Stem Cells Unit, Technological Park of Bizkaia, 801 A, 48160Derio, Spain. [email protected]View further author information
&
Maria dM Vivanco1 CIC bioGUNE, Cell Biology & Stem Cells Unit, Technological Park of Bizkaia, 801 A, 48160Derio, Spain. [email protected]Correspondence[email protected]
View further author information
Pages 995-1006 | Published online: 08 Aug 2011

Bibliography

  • Al-Hajj M , WichaMS, Benito-HernandezA, MorrisonSJ, ClarkeMF. Prospective identification of tumorigenic breast cancer cells.Proc. Natl Acad. Sci. USA100(7), 3983–3988 (2003).
  • Ginestier C , HurMH, Charafe-JauffretEet al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5), 555–567 (2007).
  • Pece S , TosoniD, ConfalonieriSet al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140(1), 62–73 (2010).
  • Bocchinfuso WP , KorachKS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice.J. Mammary Gland Biol. Neoplasia2(4), 323–334 (1997).
  • Burchell J , DurbinH, Taylor-PapadimitriouJ. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells.J. Immunol.131(1), 508–513 (1983).
  • Gudjonsson T , VilladsenR, NielsenHL, Ronnov-JessenL, BissellMJ, PetersenOW. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.Genes Dev.16(6), 693–706 (2002).
  • Gusterson BA , MonaghanP, MahendranR, EllisJ, O’HareMJ. Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12.J. Natl Cancer Inst.77(2), 343–349 (1986).
  • Koukoulis GK , VirtanenI, KorhonenM, LaitinenL, QuarantaV, GouldVE. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.Am. J. Pathol.139(4), 787–799 (1991).
  • Tsai YC , LuY, NicholsPW, ZlotnikovG, JonesPA, SmithHS. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis.Cancer Res.56(2), 402–404 (1996).
  • Alvi AJ , ClaytonH, JoshiCet al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 5(1), R1–R8 (2003).
  • Clayton H , TitleyI, VivancoM. Growth and differentiation of progenitor/stem cells derived from the human mammary gland.Exp. Cell Res.297(2), 444–460 (2004).
  • Dontu G , AbdallahWM, FoleyJMet?al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17(10), 1253–1270 (2003).
  • Sophos NA , VasiliouV. Aldehyde dehydrogenase gene superfamily: the 2002 update.Chem. Biol. Interact.143–144, 5–22 (2003).
  • Villadsen R , FridriksdottirAJ, Ronnov-JessenLet al. Evidence for a stem cell hierarchy in the adult human breast. J. Cell Biol. 177(1), 87–101 (2007).
  • Eirew P , StinglJ, RaoufAet al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 14(12), 1384–1389 (2008).
  • Lim E , VaillantF, WuDet al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15(8), 907–913 (2009).
  • Simoes BM , PivaM, IriondoOet al. Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res. Treat. DOI: 10.1007/s10549-010-1169-4 (2010) (Epub ahead of print).
  • Riekstina U , CakstinaI, ParfejevsVet al. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. Rep. 5(4), 378–386 (2009).
  • Kristensen DM , NielsenJE, KaliszMet al. OCT4 and downstream factors are expressed in human somatic urogenital epithelia and in culture of epididymal spheres. Mol. Hum. Reprod. 16(11), 835–845 (2010).
  • Reya T , MorrisonSJ, ClarkeMF, WeissmanIL. Stem cells, cancer, and cancer stem cells.Nature414(6859), 105–111 (2001).
  • Reya T , CleversH. Wnt signalling in stem cells and cancer.Nature434(7035), 843–850 (2005).
  • Bonnet D , DickJE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat. Med.3(7), 730–737 (1997).
  • Shipitsin M , CampbellLL, ArganiPet al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11(3), 259–273 (2007).
  • Liu R , WangX, ChenGYet al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 356(3), 217–226 (2007).
  • Honeth G , BendahlPO, RingnerMet al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 10(3), R53 (2008).
  • Wong DJ , LiuH, RidkyTW, CassarinoD, SegalE, ChangHY. Module map of stem cell genes guides creation of epithelial cancer stem cells.Cell Stem Cell2(4), 333–344 (2008).
  • Li X , LewisMT, HuangJet al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst. 100(9), 672–679 (2008).
  • Sheridan C , KishimotoH, FuchsRKet al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8(5), R59 (2006).
  • Abraham BK , FritzP, McclellanM, HauptvogelP, AthelogouM, BrauchH. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.Clin. Cancer Res.11(3), 1154–1159 (2005).
  • Balic M , LinH, YoungLet al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res. 12(19), 5615–5621 (2006).
  • Charafe-Jauffret E , GinestierC, IovinoFet al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin. Cancer Res. 16(1), 45–55 (2010).
  • Ben-Porath I , ThomsonMW, CareyVJet al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40(5), 499–507 (2008).
  • Rodriguez-Pinilla SM , SarrioD, Moreno-BuenoGet al. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod. Pathol. 20(4), 474–481 (2007).
  • Chen Y , ShiL, ZhangLet al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J. Biol. Chem. 283(26), 17969–17978 (2008).
  • Alldridge L , MetodievaG, GreenwoodCet al. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J. Proteome Res. 7(4), 1458–1469 (2008).
  • Fillmore CM , KuperwasserC. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.Breast Cancer Res.10(2), R25 (2008).
  • Charafe-Jauffret E , GinestierC, IovinoFet al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69(4), 1302–1313 (2009).
  • Kondo T , SetoguchiT, TagaT. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proc. Natl Acad. Sci. USA101(3), 781–786 (2004).
  • Patrawala L , CalhounT, Schneider-BroussardR, ZhouJ, ClaypoolK, TangDG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.Cancer Res.65(14), 6207–6219 (2005).
  • Engelmann K , ShenH, FinnOJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.Cancer Res.68(7), 2419–2426 (2008).
  • Ponti D , CostaA, ZaffaroniNet al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65(13), 5506–5511 (2005).
  • Cariati M , NaderiA, BrownJPet al. α6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int. J. Cancer 122(2), 298–304 (2008).
  • Jeter CR , BadeauxM, ChoyGet al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27(5), 993–1005 (2009).
  • Vivanco M . Function follows form: defining mammary stem cells.Sci. Transl. Med.2(31), 31PS22 (2010).
  • Glass CK . Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers.Endocr. Rev.15(3), 391–407 (1994).
  • Green S , WalterP, KumarVet al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320(6058), 134–139 (1986).
  • Kuiper GG , EnmarkE, Pelto-HuikkoM, NilssonS, GustafssonJA. Cloning of a novel receptor expressed in rat prostate and ovary.Proc. Natl Acad. Sci. USA93(12), 5925–5930 (1996).
  • Kuiper GG , CarlssonB, GrandienKet al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138(3), 863–870 (1997).
  • Ricketts D , TurnbullL, RyallGet al. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51(7), 1817–1822 (1991).
  • Speirs V , SklirisGP, BurdallSE, CarderPJ. Distinct expression patterns of ER α and ER β in normal human mammary gland.J. Clin. Pathol.55(5), 371–374 (2002).
  • Couse JF , KorachKS. Estrogen receptor null mice: what have we learned and where will they lead us?Endocr. Rev.20(3), 358–417 (1999).
  • Perusinghe NP , MonaghanP, O’HareMJ, AshleyS, GustersonBA. Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture.In Vitro Cell Dev. Biol.28A(2), 90–96 (1992).
  • Clarke RB , HowellA, PottenCS, AndersonE. Dissociation between steroid receptor expression and cell proliferation in the human breast.Cancer Res.57(22), 4987–4991 (1997).
  • Russo J , AoX, GrillC, RussoIH. Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland.Breast Cancer Res. Treat.53(3), 217–227 (1999).
  • Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int. J. Cancer127(12), 2893–2917 (2010).
  • Cleator SJ , AhamedE, CoombesRC, PalmieriC. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer.Clin. Breast Cancer9(Suppl. 1), S6–S17 (2009).
  • Sorlie T , PerouCM, TibshiraniRet al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98(19), 10869–10874 (2001).
  • Kurian AW , McclureLA, JohnEM, Horn-RossPL, FordJM, ClarkeCA. Second primary breast cancer occurrence according to hormone receptor status.J. Natl Cancer Inst.101(15), 1058–1065 (2009).
  • Shoker BS , JarvisC, SibsonDR, WalkerC, SloaneJP. Oestrogen receptor expression in the normal and pre-cancerous breast.J. Pathol.188(3), 237–244 (1999).
  • Knight WA , LivingstonRB, GregoryEJ, McguireWL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.Cancer Res.37(12), 4669–4671 (1977).
  • Yang XR , Chang-ClaudeJ, GoodeELet al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J. Natl Cancer Inst. 103(3), 250–263 (2011).
  • Khan SA , RogersMA, ObandoJA, TamsenA. Estrogen receptor expression of benign breast epithelium and its association with breast cancer.Cancer Res.54(4), 993–997 (1994).
  • Shoker BS , JarvisC, ClarkeRBet al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155(6), 1811–1815 (1999).
  • Roger P , SahlaME, MakelaS, GustafssonJA, BaldetP, RochefortH. Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors.Cancer Res.61(6), 2537–2541 (2001).
  • Vivanco M . Biomarkers in breast cancer.Methods Mol. Biol.593, 137–156 (2010).
  • Clemons M , GossP. Estrogen and the risk of breast cancer.N. Engl. J. Med.344(4), 276–285 (2001).
  • Planas-Silva MD , DonaherJL, WeinbergRA. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression.Cancer Res.59(19), 4788–4792 (1999).
  • Jordan VC . Tamoxifen: catalyst for the change to targeted therapy.Eur. J. Cancer44(1), 30–38 (2008).
  • Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472), 1687–1717 (2005).
  • Fisher B , CostantinoJP, WickerhamDLet al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl Cancer Inst. 97(22), 1652–1662 (2005).
  • Encarnacion CA , CioccaDR, McGuireWL, ClarkGM, FuquaSA, OsborneCK. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.Breast Cancer Res. Treat.26(3), 237–246 (1993).
  • Fisher B , CostantinoJ, RedmondCet al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N. Engl. J. Med. 320(8), 479–484 (1989).
  • Rutqvist LE , JohanssonH. Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer.Acta Oncol.46(2), 133–145 (2007).
  • Liu S , GinestierC, Charafe-JauffretEet al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl Acad. Sci. USA 105(5), 1680–1685 (2008).
  • Kok M , KoornstraRH, MargaridoTCet al. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer. J. Pathol. 218(3), 316–326 (2009).
  • Lamarca HL , RosenJM. Minireview: hormones and mammary cell fate – what will I become when I grow up?Endocrinology149(9), 4317–4321 (2008).
  • Mallepell S , KrustA, ChambonP, BriskenC. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland.Proc. Natl Acad. Sci. USA103(7), 2196–2201 (2006).
  • Ciarloni L , MallepellS, BriskenC. Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development.Proc. Natl Acad. Sci. USA104(13), 5455–5460 (2007).
  • Booth BW , BoulangerCA, AndersonLH, Jimenez-RojoL, BriskenC, SmithGH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics.Exp. Cell Res.316(3), 422–432 (2010).
  • Polyak K . Pregnancy and breast cancer: the other side of the coin.Cancer Cell9(3), 151–153 (2006).
  • Medina D . Mammary developmental fate and breast cancer risk.Endocr. Relat. Cancer12(3), 483–495 (2005).
  • Rajkumar L , KittrellFS, GuzmanRC, BrownPH, NandiS, MedinaD. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.Breast Cancer Res.9(1), R12 (2007).
  • Russo J , MoralR, BaloghGA, MailoD, RussoIH. The protective role of pregnancy in breast cancer.Breast Cancer Res.7(3), 131–142 (2005).
  • Deroo BJ , HewittSC, CollinsJB, GrissomSF, HamiltonKJ, KorachKS. Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.Mol. Reprod. Dev.76(8), 733–750 (2009).
  • Fillmore CM , GuptaPB, RudnickJAet al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc. Natl Acad. Sci. USA 107(50), 21737–21742 (2010).
  • Asselin-Labat ML , VaillantF, SheridanJMet al. Control of mammary stem cell function by steroid hormone signalling. Nature 465(7299), 798–802 (2010).
  • Joshi PA , JacksonHW, BeristainAGet al. Progesterone induces adult mammary stem cell expansion. Nature 465(7299), 803–807 (2010).
  • Schramek D , LeibbrandtA, SiglVet al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468(7320), 98–102 (2010).
  • Britt KL , KendrickH, ReganJLet al. Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells. Breast Cancer Res. 11(2), R20 (2009).
  • Siwko SK , DongJ, LewisMT, LiuH, HilsenbeckSG, LiY. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells – implications for pregnancy-induced protection against breast cancer.Stem Cells26(12), 3205–3209 (2008).
  • Chlebowski RT , AndersonGL, GassMet al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 304(15), 1684–1692 (2010).
  • Lacroix AZ , ChlebowskiRT, MansonJEet al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 305(13), 1305–1314 (2011).
  • Kalmar T , LimC, HaywardPet al. Regulated fluctuations in Nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol. 7(7), E1000149 (2009).
  • Ellis MJ , GaoF, DehdashtiFet al. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a Phase 2 randomized study. JAMA 302(7), 774–780 (2009).
  • Lewis-Wambi JS , JordanVC. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Breast Cancer Res.11(3), 206 (2009).
  • Schneider J , Martin-GutierrezS, TresguerresJA, Garcia-VelascoJA. Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.Maturitas64(1), 43–45 (2009).
  • Dean M , FojoT, BatesS. Tumour stem cells and drug resistance.Nat. Rev. Cancer5(4), 275–284 (2005).
  • Zhang M , AtkinsonRL, RosenJM. Selective targeting of radiation-resistant tumor-initiating cells.Proc. Natl Acad. Sci. USA107(8), 3522–3527 (2010).
  • Cuzick J , PowlesT, VeronesiUet al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361(9354), 296–300 (2003).
  • Dunn BK , WickerhamDL, FordLG. Prevention of hormone-related cancers: breast cancer.J. Clin. Oncol.23(2), 357–367 (2005).
  • Vogel VG , CostantinoJP, WickerhamDLet al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev. Res. (Phila.) 3(6), 696–706 (2010).
  • Liu S , DontuG, WichaMS. Mammary stem cells, self-renewal pathways, and carcinogenesis.Breast Cancer Res.7(3), 86–95 (2005).
  • Ohno R , AsouN, OhnishiK. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.Leukemia17(8), 1454–1463 (2003).
  • Gudas LJ , WagnerJA. Retinoids regulate stem cell differentiation.J. Cell Physiol.226(2), 322–330 (2011).
  • Hua S , KittlerR, WhiteKP. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.Cell137(7), 1259–1271 (2009).
  • Ginestier C , WicinskiJ, CerveraNet al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8(20), 3297–3302 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.